Shandong Luye Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHANDONG LUYE, and what generic alternatives to SHANDONG LUYE drugs are available?
SHANDONG LUYE has one approved drug.
There are five US patents protecting SHANDONG LUYE drugs.
There are twenty-seven patent family members on SHANDONG LUYE drugs in fourteen countries and one supplementary protection certificate in one country.
Drugs and US Patents for Shandong Luye
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-002 | Jan 13, 2023 | RX | Yes | Yes | 9,446,135 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-001 | Jan 13, 2023 | RX | Yes | Yes | 11,110,094 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-003 | Jan 13, 2023 | RX | Yes | Yes | 10,406,161 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-003 | Jan 13, 2023 | RX | Yes | Yes | 11,110,094 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-002 | Jan 13, 2023 | RX | Yes | Yes | 9,532,991 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-002 | Jan 13, 2023 | RX | Yes | Yes | 10,406,161 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-001 | Jan 13, 2023 | RX | Yes | Yes | 9,446,135 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Shandong Luye Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Portugal | 2701687 | ⤷ Try a Trial |
Japan | 5728128 | ⤷ Try a Trial |
European Patent Office | 3566696 | ⤷ Try a Trial |
Japan | 2014512396 | ⤷ Try a Trial |
China | 104127385 | ⤷ Try a Trial |
Spain | 2855349 | ⤷ Try a Trial |
China | 103338752 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Shandong Luye Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0196132 | 94C0008 | Belgium | ⤷ Try a Trial | PRODUCT NAME: RISPERIDONE; NAT REG.: 2 S 414 F 3 19940527; FIRST REG.: GB 0242/0186 19921208 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.